Profile
Ian Vawter worked as a Finance Director at Tissue Science Laboratories Ltd. and Covidien Unlimited Co. He then worked as a Chief Financial Officer at EDAP TMS SA. Later, he worked as a Chief Financial Officer & Vice President-Finance at BionX Medical Technologies, Inc. from 2012 to 2013.
Mr. Vawter completed his undergraduate degree from Norwich University.
Former positions of Ian Vawter
| Companies | Position | End |
|---|---|---|
| EDAP TMS S.A. | Director of Finance/CFO | - |
Covidien Unlimited Co.
Covidien Unlimited Co. Medical SpecialtiesHealth Technology Manufactures and distributes medical devices and pharmaceuticals | Director of Finance/CFO | - |
Tissue Science Laboratories Ltd.
Tissue Science Laboratories Ltd. Medical SpecialtiesHealth Technology Develops and markets tissue implant products | Director of Finance/CFO | - |
BionX Medical Technologies, Inc.
BionX Medical Technologies, Inc. Medical SpecialtiesHealth Technology Designs and manufactures prosthetic devices | Director of Finance/CFO | - |
Training of Ian Vawter
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 5 |
|---|---|
EDAP TMS SA
EDAP TMS SA Medical SpecialtiesHealth Technology Develops, produces and markets minimally invasive medical devices for urological diseases | Health Technology |
BionX Medical Technologies, Inc.
BionX Medical Technologies, Inc. Medical SpecialtiesHealth Technology Designs and manufactures prosthetic devices | Health Technology |
Tissue Science Laboratories Ltd.
Tissue Science Laboratories Ltd. Medical SpecialtiesHealth Technology Develops and markets tissue implant products | Health Technology |
Norwich University
Norwich University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Covidien Unlimited Co.
Covidien Unlimited Co. Medical SpecialtiesHealth Technology Manufactures and distributes medical devices and pharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Ian Vawter
















